Clinico-pathological Profile and Outcome of C-3 Glomerulopathy in Indian Children.
| Autor: | Prakash, Richa, Ali, Uma S., Ohri, Alpana, Parekhji, Shashank Nitin, Deokar, Atul, Khubchandani, Shaila |
|---|---|
| Předmět: |
BIOPSY
CHRONIC kidney failure FLUORESCENT antibody technique GLOMERULAR filtration rate GLOMERULONEPHRITIS HEMATURIA LONGITUDINAL method MICROSCOPY NEPHROTIC syndrome PROTEINURIA SURVIVAL analysis (Biometry) THERAPEUTICS DESCRIPTIVE statistics KAPLAN-Meier estimator RENAL replacement therapy CHILDREN |
| Zdroj: | Indian Journal of Nephrology; Nov/Dec2020, Vol. 30 Issue 6, p370-376, 7p |
| Abstrakt: | Introduction: There is paucity of data of C3 glomerulopathy in Indian children. Methods: First Indian pediatric case series where consecutive renal biopsies done over a period of ten years were reviewed to identify those patients who had isolated or predominant C3 deposits on immunofluorescent microscopy, fulfilling the criteria for C-3 glomerulopathy. The clinical, biochemical, serological, histopathological profile, eGFR and the need for renal replacement therapy was analyzed. Results: Eighteen patients, comprising 5.3% (18/298) of all renal biopsies, had C3 glomerulopathy, four with Dense Deposit Disease (DDD) and fourteen with C3 Glomerulonephritis (C3GN) with a median follow-up of 38.2 months. Median age of presentation was 7.45±3.03 years (2.5yrs- 13.5yrs) with nine boys and nine girls. Presentation was nephrotic syndrome in seven (39%), acute nephritic syndrome in three (16.7%), hematuria in five (27.7%) and acute kidney injury in three (16.7%). Median eGFR was 69 ml/min/1.73m2 (8.2-107 ml/min/1.73m²). Hematuria was seen in 16 (88%), proteinuria in 18 (100%) and low C3 in 16 (88%) at the time of presentation. Mesangioproliferative glomerulonephritis was the predominant pattern in DDD while C3GN showed a mix of mesangioproliferative, membranoproliferative, endocapillary and crescentic GN (p = 0.43). Complete or partial remission was seen in seven patients who received long term alternate day steroids alone or with added mycophenolate mofetil. The cumulative patient survival was 70.8%. Kaplan Meir analyses for renal survival without progression to ESRD was 60.2% at one year and 48.1% at five and ten years. Conclusion: Interstitial fibrosis and tubular atrophy on renal biopsy was an independent predictor of adverse renal outcome in the cohort (p = 0.013, HR8.1;95% CI -1.6-42). [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|